8 results
·
18ms
·
Sources: EU EUDAMED, US FDA
LYME DISEASE B. BURGDORFERI GENOGROUP 1 WESTERN BLOT IGM (WB0400M)
FDA 510(k)
FDA Class 2
·Microbiology
HEARTWAY LIGHTWEIGHT POWER MOBILITY SCOOTER, S33
FDA 510(k)
FDA Class 2
·Physical Medicine
Fluorescence Mode
FDA 510(k)
FDA Class 2
·Dental
HEMOCHRON SIGNATURE ELITE
FDA Adverse Event
Malfunction
·ACCRIVA DIAGNOSTICS·Product code JPA·May 25, 2016
TI OCCIPITAL PLATE LATERAL WEDGE/60MM WIDTH
FDA Adverse Event
Injury
·SYNTHES GMBH·Product code HRS·February 21, 2013
UNKNOWN ZIMMER KNEE
FDA Adverse Event
Malfunction
·ZIMMER INC.·Product code JWH·January 6, 2011
UNK HA DERMAL FILLER
FDA Adverse Event
Injury
·ALLERGAN·Product code LMH·July 8, 2014
Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017